Zobrazeno 1 - 10
of 502
pro vyhledávání: '"B. Borg"'
Publikováno v:
Journal of Applied Poultry Research, Vol 32, Iss 2, Pp 100337- (2023)
SUMMARY: The soybean supply chain incentivizes upstream participants (farmers) to maximize crop yield (volume), while downstream participants (nutritionists) make decisions based on crop quality characteristics such as amino acid concentration and en
Externí odkaz:
https://doaj.org/article/a2436adf10104ce3b8d9a087955e7dc5
Publikováno v:
eLife, Vol 11 (2022)
Acid-sensing ion channels (ASICs) are trimeric proton-gated cation channels involved in fast synaptic transmission. Pharmacological inhibition of ASIC1a reduces neurotoxicity and stroke infarct volumes, with the cysteine knot toxin psalmotoxin-1 (PcT
Externí odkaz:
https://doaj.org/article/df550b8f381442e89603d22f8c872206
Publikováno v:
European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): Dean's funds of the University of Malta Medical School. Background Type 2 diabetes mellitus (T2DM) is a known major risk factor for cardiovascular diseas
Publikováno v:
B55. GETTING TO THE HEART OF CARDIOPULMONARY ANOMALIES AND DIAGNOSTIC DILEMMAS IN PH.
Autor:
N. Holt, C.L. Smith, C.X. Gao, B. Borg, T.J. Lane, D. Brown, J. Ikin, A. Makar, T. McCrabb, M. Mikayla, K. Nilsen, B.R. Thompson, M.J. Abramson
Publikováno v:
B105. SICK ON THE JOB: UNCOVERING MODERN OCCUPATIONAL HAZARDS.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:S141-S142
Autor:
Christian B. Borg, Matteo Lambrughi, Elisabeth Corcelle-Termeau, Isha Raj, Ditte L. Fogde, Emiliano Maiani, Simone Scrima, Kenji Maeda, Nicholas M.I. Taylor, Marja Jäättelä, Elena Papaleo
Publikováno v:
Biophysical Journal. 122:57a-58a
Autor:
Deven Parmar, Mohammad S. Siddiqui, Ziad Younes, Douglas Denham, Michael O. Idowu, Donald Lazas, Arun J. Sanyal, Brian B. Borg, Nicole M. Loo
Publikováno v:
Clinical Gastroenterology and Hepatology. 19:2670-2672
Nonalcoholic steatohepatitis (NASH), the clinically aggressive variant of nonalcoholic fatty liver disease, is characterized by hepatocellular injury and inflammation.1 Patients with NASH are at higher risk of progression to cirrhosis and it is there
Autor:
Guadalupe Garcia-Tsao, Jaime Bosch, Zeid Kayali, Stephen A. Harrison, Manal F. Abdelmalek, Eric Lawitz, Sanjaya K. Satapathy, Marwan Ghabril, Mitchell L. Shiffman, Ziad H. Younes, Paul J. Thuluvath, Annalisa Berzigotti, Agustin Albillos, James M. Robinson, David T. Hagerty, Jean L. Chan, Arun J. Sanyal, M. Abdelmalek, K. Bhamidimarri, B. Borg, S. Caldwell, J. Fenkel, B. Freilich, M. Fuchs, M. Ghabril, R. Ghalib, S. Gonzalez, S. Gordon, B. Hameed, S. Harrison, Z. Kayali, N. Kemmer, K. Korenblat, M. Lai, C. Landis, E. Lawitz, W. Lee, S. Lidofsky, E. Mena, M. Noureddin, A. Paredes, N. Pyrsopoulos, R. Reddy, M. Rinella, D. Rockey, M. Rodriguez, M. Ryan, S. Sarkar, S. Satapathy, A. Scanga, M. Shiffman, M. Siddiqui, D. Simonetto, W. Syn, P. Thuluvath, R. Vemulapalli, J. Vierling, Z. Younes, A. Albillos, J. Arenas Ruiz-Tapiador, S. Augustin, J. Calleja, J. Crespo Garcia, L. Garcia Buey, J.C. Garcia-Pagan, C. Villanueva, C. Bureau, N. Carbonell, V. Leroy, P.-E. Rautou, H. Heinzow, I. Schiefke, A. Zipprich, A. Berzigotti, B. Muellhaupt
Publikováno v:
Garcia-Tsao, Guadalupe; Bosch, Jaime; Kayali, Zeid; Harrison, Stephen A; Abdelmalek, Manal F; Lawitz, Eric; Satapathy, Sanjaya K; Ghabril, Marwan; Shiffman, Mitchell L; Younes, Ziad H; Thuluvath, Paul J; Berzigotti, Annalisa; Albillos, Agustin; Robinson, James M; Hagerty, David T; Chan, Jean L; Sanyal, Arun J (2020). Randomized Placebo-Controlled Trial of Emricasan in Non-alcoholic Steatohepatitis (NASH) Cirrhosis with Severe Portal Hypertension. Journal of hepatology, 72(5), pp. 885-895. Elsevier 10.1016/j.jhep.2019.12.010
Background & Aims Emricasan, an oral pan-caspase inhibitor, decreased portal pressure in experimental cirrhosis and in an open-label study in patients with cirrhosis and severe portal hypertension, defined as a hepatic venous pressure gradient (HVPG)